MedTrace Logo

Acoustic Stimulation During Sleep: Effects on Memory and p-tau217 in MCI

NCT07529015 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 114

Last updated 2026-04-14

No results posted yet for this study

Summary

The goal of this clinical trial is to determine whether acoustic stimulation during sleep can enhance slow-wave sleep (SWS), improve cognitive function, and reduce AD-related pathology in individuals with mild cognitive impairment (MCI), compared with cognitively healthy participants.

The main questions it aims to answer are:

1. Does acoustic stimulation increase SWS (e.g., slow oscillation and sleep spindle activity) in individuals with MCI?
2. Does enhancing SWS lead to improvements in memory and cognitive performance?
3. Does acoustic stimulation influence plasma p-tau217 levels as a marker of underlying Alzheimer's disease pathology? Researchers will compare participants receiving acoustic stimulation during sleep with those not receiving stimulation to evaluate its effects on sleep architecture, cognition, and plasma biomarkers.

Participants will:

* Undergo sleep recordings to assess sleep architecture, including SWS, slow oscillations, and sleep spindles
* Receive acoustic stimulation during sleep across multiple nights
* Complete cognitive assessments, particularly memory-related tasks
* Provide blood samples to measure plasma p-tau217 levels
* Provide clinical and demographic information for analysis

Conditions

  • Alzheimer's Disease (AD)
  • Mild Cognitive Impairment (MCI) Amnestic
  • Cognitively Unimpaired

Interventions

DEVICE

Plase-Locked Acoustic Stimulation during slow-wave sleep

Participants will wear a mobile, wearable EEG device during sleep. Sleep will be recorded using EEG, and an algorithm will detect slow oscillations (SOs; \>1 Hz). In the real-PLAS arm, acoustic stimulation will be applied in phase with the up-state of these slow oscillations. Specifically, the algorithm will detect each SO and trigger brief pink-noise bursts synchronized with the up-state phase, ensuring phase-locked acoustic stimulation (PLAS) is delivered precisely to enhance slow-wave activity.

DEVICE

Phase-locked acoustic stimulation-Sham condition

Participants will have the same setup as in the real-PLAS arm, wearing a mobile, wearable EEG device during sleep. Sleep will be recorded using EEG, and an algorithm will detect slow oscillations (SOs; \>1 Hz). No acoustic stimulation will be applied in the sham-PLAS arm.

Sponsors & Collaborators

  • Institut de Recerca Biomèdica de Lleida-Fundació Dr. Pifarré (IRBLleida)

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-04-30
Primary Completion
2027-09-30
Completion
2028-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07529015 on ClinicalTrials.gov